Pancreatic cancer

First-in-Class Pancreatic Cancer Candidate Gets Fast Track Status

By March 01, 2018

Pamrevlumab is a first-in-class antibody developed by FibroGen to inhibit the activity of connective tissue growth factor.

New App May Help Screen for Pancreatic Cancer via Selfie

By August 29, 2017

The 'BiliScreen' app uses a smartphone camera; by taking a picture of the user's eyes it can calculate the color formation of the sclera and correlates it to the correct bilirubin level

Pancreatic Enzyme Replacement Beneficial for Pancreatic Cancer Patients

By July 17, 2017

Data on nutritional markers (body mass index [BMI], albumin, total cholesterol) were collected at baseline and then assessed at 16 weeks; change from baseline was compared between the two groups.

Novel Pancreatic Cancer Treatment Granted Orphan Drug Status

By December 14, 2016

Ability Pharmaceuticals has announced that the Food and Drug Administration has granted orphan drug designation to ABTL0812, an investigational candidate for pancreatic cancer.

Insulin-Related CA Risks May Be Offset by Statin Use

October 26, 2016

For patients with type 2 diabetes mellitus (T2DM), use of statins offsets insulin-related cancer risks, according to research published online in the Journal of Internal Medicine.

Recent Pancreatic Cancer Findings May Open Door for Novel Treatments

February 26, 2016

Scientists who discovered that pancreatic cancer is at least four separate diseases say their findings could lead to improved treatments for the disease.

Concerns Over Incretin-Based Drugs, Pancreatic Cancer Risk Addressed in New Study

By February 22, 2016

A new international, multicenter study has found that incretin-based drugs, used to treat type 2 diabetes, are not associated with an increased risk of pancreatic cancer.

Can Metformin be Beneficial in Slowing Pancreatic Cancer?

By January 14, 2016

Metformin may inhibit the progression of pancreatic cancer by decreasing inflammation and fibrosis, a study published in PLOS One reported.